What is AtriCure's cash & equivalents?

AtriCure (ATRC) reported cash & equivalents of $146.17M in Q1 2026.

How has AtriCure's cash & equivalents changed year-over-year?

AtriCure's cash & equivalents increased by 46.3% year-over-year, from $99.89M to $146.17M.

What is the long-term trend for AtriCure's cash & equivalents?

Over 5 years (2020 to 2025), AtriCure's cash & equivalents has grown at a 31.9% compound annual growth rate (CAGR), from $41.94M to $167.43M.

What does cash & equivalents mean?

Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.

AtriCure ATRC Cash & Equivalents

Cash & Equivalents at other companies

AbbottABT

$6.8B+4.1%

Johnson & JohnsonJNJ

$21.69B-43.6%

Boston ScientificBSX

$850M+146%

MedtronicMDT

$1.95B-12.1%

Pulse Biosciences, Inc.PLSE

$68.32M-42.7%

ITG

Integer HoldingsITGR

$8.12M-74.4%

Other financials

Income statement

See full

Revenue$141.2M+14.3%

Gross profit$109.3M+18.0%

Operating income$526.0K+109%

Net income$108.0K+102%

EPS (diluted)$0.00+100%

Balance sheet

See full

Total debt$76.2M-3.1%

Total equity$491.7M+8.2%

Total assets$644.0M+8.8%

Cash flow

See full

Operating cash flow-$4.0M+63.8%

CapEx$3.9M+76.6%

Free cash flow-$7.8M+40.6%

Valuation

See full

Market cap$1.43B-9.9%

Enterprise value$1.36B-13.1%

P/S2.6×-0.7×

Profitability

See full

Gross margin75.6%+0.8pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.7%—

Returns & leverage

See full

Return on equity-6.1%-1.3pp

Debt / equity0.2×0.0×

Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's cash & equivalents.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AtriCure's cash & equivalents?: AtriCure (ATRC) reported cash & equivalents of $146.17M in Q1 2026.
How has AtriCure's cash & equivalents changed year-over-year?: AtriCure's cash & equivalents increased by 46.3% year-over-year, from $99.89M to $146.17M.
What is the long-term trend for AtriCure's cash & equivalents?: Over 5 years (2020 to 2025), AtriCure's cash & equivalents has grown at a 31.9% compound annual growth rate (CAGR), from $41.94M to $167.43M.
What does cash & equivalents mean?: Cash on hand plus highly liquid investments with maturities of three months or less at purchase — treasury bills, money market funds, and commercial paper.